• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The effect of posttransplant cyclophosphamide on ocular graft-versus-host disease.

作者信息

Menghesha Leonie, Tahmaz Volkan, Holtick Udo, Scheid Christof, Stern Michael E, Steven Philipp

机构信息

Competence Center for Ocular GVHD, Clinic I of Internal Medicine and Department of Ophthalmology, University of Cologne, Cologne, Germany.

Department of Ophthalmology, St. Elisabeth Hospital Hohenlind, Cologne, Germany.

出版信息

Bone Marrow Transplant. 2025 May 30. doi: 10.1038/s41409-025-02628-9.

DOI:10.1038/s41409-025-02628-9
PMID:40447790
Abstract
摘要

相似文献

1
The effect of posttransplant cyclophosphamide on ocular graft-versus-host disease.移植后环磷酰胺对眼部移植物抗宿主病的影响。
Bone Marrow Transplant. 2025 May 30. doi: 10.1038/s41409-025-02628-9.
2
Impact of Graft-Versus-Host Disease on Relapse and Nonrelapse Mortality Following Posttransplant Cyclophosphamide-Based Transplantation.移植物抗宿主病对基于移植后环磷酰胺的移植后复发及非复发死亡率的影响
Transplant Cell Ther. 2024 Sep;30(9):903.e1-903.e9. doi: 10.1016/j.jtct.2024.06.015. Epub 2024 Jun 13.
3
Treatment-Responsive Acute Graft-versus-Host Disease after Post-Transplantation Cyclophosphamide-Based Prophylaxis: Incidence and Clinical Outcomes.移植后环磷酰胺预防治疗后发生的治疗反应性急性移植物抗宿主病：发生率和临床结局。
Transplant Cell Ther. 2024 Jul;30(7):688.e1-688.e9. doi: 10.1016/j.jtct.2024.05.007. Epub 2024 May 9.
4
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation.基于移植后环磷酰胺与基于甲氨蝶呤/钙调神经磷酸酶抑制剂的异基因造血细胞移植的慢性移植物抗宿主病的严重程度及器官分布情况
Bone Marrow Transplant. 2024 Mar;59(3):373-379. doi: 10.1038/s41409-023-02178-y. Epub 2024 Jan 4.
5
Redefining GVHD Prophylaxis: The Expanding Horizon of Posttransplant Cyclophosphamide.
Adv Exp Med Biol. 2025 Jun 28. doi: 10.1007/5584_2025_873.
6
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Myelofibrosis.骨髓纤维化患者接受移植后环磷酰胺预防移植物抗宿主病后的植入不良
Am J Hematol. 2025 Sep;100(9):1513-1522. doi: 10.1002/ajh.27741. Epub 2025 Jun 12.
7
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.一项关于移植后环磷酰胺和阿巴西普预防移植物抗宿主病的前瞻性临床试验。
Blood Adv. 2025 Aug 26;9(16):4336-4344. doi: 10.1182/bloodadvances.2024015094.
8
Antithymocyte globulin and posttransplant cyclophosphamide in graft vs. host disease prophylaxis: comparison or combination.
Curr Opin Hematol. 2025 Jul 8. doi: 10.1097/MOH.0000000000000882.
9
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.西罗莫司可作为移植后环磷酰胺方案用于亲缘单倍体外周血造血干细胞移植后移植物抗宿主病预防时他克莫司的可接受替代药物。
Transplant Cell Ther. 2024 Feb;30(2):229.e1-229.e11. doi: 10.1016/j.jtct.2023.11.010. Epub 2023 Nov 11.
10
Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens.基于环磷酰胺/全身照射方案的预处理方案和移植物抗宿主病预防措施对脐带血移植结局的影响。
Transplant Cell Ther. 2024 Mar;30(3):318.e1-318.e11. doi: 10.1016/j.jtct.2023.12.004. Epub 2023 Dec 9.

本文引用的文献

1
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.移植后环磷酰胺为基础的移植物抗宿主病预防。
N Engl J Med. 2023 Jun 22;388(25):2338-2348. doi: 10.1056/NEJMoa2215943.
2
Desiccating Stress Significantly Increases the Risk for Chronic Ocular Graft-versus-Host-Disease.干燥应激显著增加慢性眼部移植物抗宿主病的风险。
Transplant Cell Ther. 2022 Nov;28(11):782.e1-782.e7. doi: 10.1016/j.jtct.2022.07.027. Epub 2022 Jul 31.
3
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report.
美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识开发项目：IIa. 2020 年临床实施和早期诊断工作组报告。
Transplant Cell Ther. 2021 Jul;27(7):545-557. doi: 10.1016/j.jtct.2021.03.033. Epub 2021 Apr 9.
4
Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2020 Sep;55(9):1851-1853. doi: 10.1038/s41409-020-0824-6. Epub 2020 Feb 10.
5
Posttransplant cyclophosphamide in allogeneic bone marrow transplantation for the treatment of nonmalignant hematological diseases.异基因骨髓移植中应用环磷酰胺治疗非恶性血液病。
Bone Marrow Transplant. 2020 Apr;55(4):758-762. doi: 10.1038/s41409-019-0725-8. Epub 2019 Oct 24.
6
A cross-sectional study on vision-related quality of life in patients with ocular GvHD.一项关于眼部移植物抗宿主病患者视力相关生活质量的横断面研究。
Bone Marrow Transplant. 2015 Sep;50(9):1224-6. doi: 10.1038/bmt.2015.24. Epub 2015 Jun 8.
7
Meibography and meibomian gland measurements in ocular graft-versus-host disease.眼部移植物抗宿主病的睑板腺造影及睑板腺测量
Bone Marrow Transplant. 2015 Jul;50(7):961-7. doi: 10.1038/bmt.2015.72. Epub 2015 Apr 20.